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Investigation of solid–liquid phase diagrams of the
sulfamethazine–salicylic acid co-crystal†
Dipali Ahuja, a Michael Svärd *ab and Åke C. Rasmuson*ab
The influence of temperature and solvent on the solid–liquid phase diagram of the 1 : 1 sulfamethazine–
salicylic acid co-crystal has been investigated. Ternary phase diagrams of this co-crystal system have been
constructed in three solvents: methanol, acetonitrile and a 7 : 3 (v/v) dimethylsulfoxide–methanol mixture,
at three temperatures. The system exhibits congruent dissolution in acetonitrile and the co-crystal solubility
has been determined by a gravimetric technique. The Gibbs energy of co-crystal formation from the re-
spective solid components has been estimated from solubility data, together with the corresponding
enthalpic and entropic component terms. The Gibbs energy of formation ranges from −5.7 to −7.7 kJ
mol−1, with the stability increasing with temperature. In methanol and the DMSO–methanol mixture, the
co-crystal dissolves incongruently. It is shown that the solubility ratio of the pure components cannot be
used to predict with confidence whether the co-crystal will dissolve congruently or incongruently. The size
of the region where the co-crystal is the only stable solid phase is inversely related to the pure component
solubility ratio of salicylic acid and sulfamethazine.
Introduction
Co-crystals are crystalline molecular complexes comprising
two or more neutral components that in pure form are solid
at room temperature. The components appear in the co-
crystal in a specific stoichiometry, bonded by non-covalent in-
teractions, especially hydrogen bonding. Co-crystals are of
considerable interest to the pharmaceutical industry because
of their ability to modify the physical properties of the active
pharmaceutical ingredient (API), without affecting the molec-
ular structure.1–3 Co-crystal formation has indeed proved to
be a useful tool to alter a wide range of properties including
melting point, hygroscopicity, dissolution rate, thermal stabil-
ity, solubility and hence bioavailability.4–10 Different methods
can be used to synthesize co-crystals, such as dry and wet
grinding,11–17 evaporation crystallization,18–21 spray
drying,22–24 and sonication,25–27 but solution and cooling crys-
tallization remain the most popular for scale up.16,28–31 A few
other methods for co-crystal synthesis including hot melt ex-
trusion,32 supercritical fluid technology33,34 and laser irradia-
tion,35 have been reported in literature. Most research on co-
crystals so far has focused on finding new co-crystals and
rationalising whether co-crystals will be formed or not. Much
less work has focused on their physical properties and how
these depend on the coformer.36–38 There is also a limited
amount of work performed so far on various aspects of their
manufacturing.39–41
For design and operation of a crystallization process for
the manufacture of co-crystals, a complete and detailed
phase diagram is crucial as it reveals the stability regions for
the different crystalline phases. Based on a proper phase dia-
gram identifying the region where the co-crystal is the stable
solid phase, the conditions for manufacturing can be deter-
mined. Parameters like solvent and temperature can signifi-
cantly affect the solubility of the co-crystal and alter the
shape of the phase diagram.28,42 It has been suggested that a
large solubility difference between the two components most
likely leads to an incongruent system.42 Of general impor-
tance is whether the co-crystal dissolves congruently or not,
the width of the region where the co-crystal is stable, and the
co-crystal solubility. The wider the co-crystal region, the more
robust the process of manufacturing becomes. If the co-
crystal dissolves congruently a simple cooling crystallization
can be performed, and the design of the process is even more
facilitated. However, if the starting solution composition is
adjusted appropriately,19,20 a non-congruent system is no ma-
jor obstacle as long as the co-crystal region is not too narrow.
It is important to understand the co-crystal stability and
formation in terms of key thermodynamic parameters like
Gibbs energy. In the literature, only a few studies specifically
treat thermodynamics of co-crystals. Nehm et al. defined
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the solubility product of a co-crystal as the product of the
component concentrations and demonstrated it for the car-
bamazepine–nicotinamide co-crystal system.43 In 2007,
Chiarella et al. showed that crystallization from a solution
containing stoichiometric amounts of pure components
might or might not form pure co-crystal based on solvent
choice, and explained this on the basis of phase diagrams for
the 1 : 1 trans-cinnamic acid–nicotinamide co-crystal.28 The
factors responsible for the formation and stability of co-
crystals with different stoichiometry using carbamazepine–4-
aminobenzoic acid as a model system have been identified by
Rodríguez-Hornedo et al.44 ter Horst et al. utilized thermody-
namic principles to develop a method for co-crystal screen-
ing.45 In 2012, Leyssens et al. showed the importance of the
solvent for synthesis and stability of diverse stoichiometric
caffeine–maleic acid co-crystals.46 In acetone where the rela-
tive solubility between the pure components is high, the 2 : 1
co-crystal is inaccessible, whereas in ethyl acetate with a re-
duced relative solubility, this zone becomes accessible.
Croker et al. reported the formation of a new co-crystal with
p-toluenesulfonamide and triphenylphosphine and studied
the effect of the solvent by constructing phase diagrams in
two solvents: acetonitrile and dichloromethane.19 Zhang and
Rasmuson studied the thermodynamics and crystallization of
theophylline–oxalic acid and theophylline–glutaric acid 1 : 1
co-crystals.47,48 They estimated Gibbs energies of co-crystal
formation from solubility data and investigated the effect of
polymorphism on the phase diagrams. In 2017, Bacchi et al.
constructed ternary phase diagrams for a liquid API,
propofol, with solid coformers: bipyridine and phenazine.49
They employed co-crystallization to stabilize the liquid drug
in a crystalline form.
Sulfonamides are considered able to form co-crystals, as
they possess both hydrogen bond donor and acceptor groups.
Sulfamethazine (SMT), a sulfonamide drug, is an antimicro-
bial and an anti-infective agent. It is used as a veterinary
medicine to treat a variety of infections. In humans, it is used
for the treatment of urinary tract infection, chlamydia, ma-
laria, rheumatoid fever and toxoplasmosis.50 It belongs to the
BCS class II, i.e. it is known to have a high permeability but a
low solubility, and consequently a low bioavailability. For
pure solid SMT, only one pure component crystal structure
has been reported, belonging to the monoclinic crystal sys-
tem.51,52 SMT can form co-crystals with several carboxylic
acids. A 1 : 1 co-crystal between SMT and salicylic acid (SA)
has been reported.53 The chemical structures of SMT and SA
are depicted in Fig. 1.
In this work, the SMT–SA co-crystal system is used as a
model for construction and analysis of phase diagrams. We
have investigated the thermodynamics of the SMT–SA co-
crystal in three different solvent systems. Ternary phase dia-
grams have been constructed in methanol and acetonitrile at
10, 20, 30 °C and in a 7 : 3 (v/v) dimethyl sulfoxide–methanol
mixture at 20, 30 and 40 °C. The objectives of this work in-
clude identifying the stability regions of the co-crystal in the
three solvent systems, and studying the effect of coformer
solubility and temperature on the appearance, shape, and
symmetry of the phase diagrams. We have also estimated the
Gibbs energy of co-crystal formation from the solubility data.




Sulfamethazine (CAS Registry Number 57-68-1), purity >99%,
salicylic acid (CAS Registry Number 69-72-7), purity >99%
and methanol (CAS Registry Number 67-56-1, HPLC grade,
purity >99.9%) were purchased from Sigma-Aldrich. Acetoni-
trile (CAS Registry Number 75-05-8, HPLC grade, purity
>99.9%) was purchased from Fisher Chemicals and dimethyl
sulfoxide (CAS Registry Number 67-68-5, purity >99.8%) was
purchased from Acros Organics. All the chemicals were used
as received. Necessary precautions were taken to minimize
exposure of solvents to the moisture in ambient air – in par-
ticular for DMSO due to its hygroscopic nature.
Solvents were selected with the ambition to cover congru-
ent as well as incongruent conditions, with the starting point
in the expectation that a symmetric and congruent system
would be obtained when the pure components had similar
solubility, and asymmetric and incongruent systems obtained
for larger solubility differences. Preliminary solubility experi-
ments were carried out, based on which the three solvent sys-
tems were selected. The solvents evaluated were methanol,
acetonitrile, water, chloroform, acetone, ethyl acetate, di-
methyl sulfoxide, N,N-dimethyl acetamide, N,N-dimethyl
formamide, and dimethyl sulfoxide–methanol mixtures of
different ratios. The preliminary solubility experiments re-
vealed a high SA to SMT solubility ratio in ethyl acetate and
in methanol. Methanol was chosen as an example of a likely
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incongruent dissolution over ethyl acetate on the basis of a
higher SMT solubility. In acetonitrile the solubility ratio was
lower than in acetone, and was selected as a likely congruent
dissolution system. In chloroform, the settling velocity of
solid was low because of similar densities of SMT, SA and
chloroform, and in water the problem was the same. Hence,
for practical reasons, water and chloroform were not selected.
SMT exhibits about the same low solubility in all solvents
tested except for DMSO, DMA and DMF. However, SMT
forms solvates in pure DMSO, DMF and DMA.54 A few
DMSO–methanol mixtures were evaluated with the intent to
keep the DMSO content high. A 7 : 3 (v/v) DMSO–methanol
mixture, prepared by mixing 7 volume parts of DMSO and 3
volume parts of methanol, was chosen as it fulfils the three
targets, i.e. high SMT solubility, no solvate formation and a
low solubility ratio.
Equipment
PXRD data was collected in reflectance mode using an Empy-
rean diffractometer (PANalytical, Phillips) equipped with Cu
Kα1,2 radiation (γ = 1.5406 Å) operating at 40 kV and 40 mA at
room temperature. Samples were scanned between 2θ values
of 5 and 40° at a step size of 0.01313° 2θ with step time 73 s
per step on a spinning silicon holder. HPLC analysis was
performed on an “Agilent Technologies 1260 Infinity Series”
comprising of a solvent 1260 Quat delivery pump, auto-injec-
tor, absorbance UV spectrophotometric detector (275 nm) and
Agilent Chem Station software. A Macharey-Nagel EC 100/4.6
Nucleodur C18 column was used with methanol/2% acetic
acid (88/12, v/v) as the mobile phase. An OHAUS Explorer ana-
lytical balance with a resolution of 10−4 g was used for
weighing of chemicals. The solubility experiments were car-
ried out in 30 mL glass vials with magnetic stirrer bars, using
a Grant ST26 stainless steel thermostatic water bath; 26 L, 505
× 300 × 200 mm; equipped with a Grant C2G cooling unit and
a Grant GR150 control unit; stability ±0.01 °C and uniformity
±0.05 °C, with a serial submersible 60 points magnetic stirrer
plate (2Mag) placed on the base and a submersible water
pump (1400 L h−1) to enhance circulation in the bath.
Co-crystal preparation
The co-crystal was synthesized using the solvent drop grinding
method. Equimolar amounts of sulfamethazine (SMT) and
salicylic acid (SA) were finely ground for about 15–20 minutes
by hand. A few drops of acetonitrile were added followed by
further grinding for 10–15 minutes to form a white dry pow-
der. The powder was characterized by PXRD and DSC.
Determination of solubility
Solubility of the pure compounds (SMT and SA) was deter-
mined gravimetrically in methanol and acetonitrile at 10, 20
and 30 °C. HPLC was employed to determine the solubility in
7 : 3 (v/v) dimethyl sulfoxide–methanol mixture at 20, 30 and
40 °C. The first step to both the techniques involved prepar-
ing saturated solutions, for each of which an amount of solid
solute in excess of the solubility was added to ∼5 mL of the
solvent at the desired temperature. The solutions were equili-
brated for a period of 24 hours under continuous agitation.
The agitation was then stopped, and the solids allowed to set-
tle for a period of 10 minutes (methanol, acetonitrile), or 60
minutes (DMSO–methanol) due to slow settling. Samples of
the saturated supernatant clear liquid was pipetted out using
a syringe. For gravimetric determination, approx. 1 mL of the
solution was filtered into a pre-weighed glass vial (m1) using
a 0.2 μm PTFE syringe filter. The vial was weighed immedi-
ately and the mass recorded as m2. The solvent was then
allowed to evaporate by placing the vial for a sufficient time
(usually overnight) in a fume hood until dry and the mass
recorded. The dried vial was then moved to a vacuum oven at
50 °C for 1 hour, after which no further decrease in weight
could be recorded. The mass of the vial containing dry solids
(m3) was recorded. The syringes, vials and the filters were
pre-heated before sampling solutions at high temperatures.
The solubility was calculated as (m3 − m1)/(m2 − m3). Each
reported concentration value is an average of four completely
separate experiments.
Because of the high boiling point (189 °C) and accordingly
low volatility of DMSO, the gravimetric method was not feasi-
ble for DMSO–methanol solutions. Solution concentrations
were determined by HPLC for the determination of the solu-
bility of SMT and SA in this solvent system. This entailed the
construction of calibration curves i.e. peak area vs. concentra-
tion using stock solutions of known concentrations of SMT
and SA in DMSO–methanol. The calibration lines showed
good linearity (R2 = 0.99). The saturated solution samples
were filtered into clean glass vials. Peak areas for the satu-
rated solutions of SMT and SA at different temperatures were
obtained and the corresponding concentrations in turn
obtained using the calibration curves.
Determination of the ternary phase diagram
Invariant points represent solution concentrations at which
two solid phases (SMT + co-crystal or SA + co-crystal) are at
equilibrium with the same solution. These points were deter-
mined by equilibrating different mixtures of the two solid co-
crystal components with the solvent and then analyzing both
the solid and the solution phase. At constant temperature,
SMT and SA were mixed with the solvent and magnetically
stirred for 24 hours to reach equilibrium. Following this, the
solid material and the saturated solution were separated by
filtration. An aliquot of the saturated solution was diluted
with pure solvent and analysed by HPLC. The concentration
of SMT and SA, respectively, was determined from the cali-
bration curves in the pure solvent. Using another aliquot of
the saturated solution, gravimetry was employed to deter-
mine the solute and solvent content in the liquid phase. The
solid material was analyzed by PXRD and DSC. The solubility
of the pure components and the concentrations correspond-
ing to the invariant points were plotted in a ternary diagram
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Process experiments
Isothermal slurry conversion experiments19,20,56 were carried
out for investigation of the manufacturing of the co-crystal.
Guided by the determined ternary phase diagram in each sol-
vent at 30 °C, two points were selected inside the region
where the co-crystal only is thermodynamically stable. The
two points were selected to compare a high and a low solid
loading (refer to Table 3 for mass fractions). Pure solid com-
ponents and the solvent were mixed in proportions corre-
sponding to each point, and the mixture was stirred for 24
hours. The solids were then separated from the solution by
filtration and allowed to dry. The mass of the dry solids was
recorded (product mass) and was confirmed by PXRD to be
co-pure crystals. The co-crystal yield was calculated as the
mass of obtained co-crystals divided by the total mass of API
and coformer used, and the volumetric productivity was cal-
culated as the mass of obtained co-crystals divided by the to-
tal slurry volume (API, coformer and solvent).
Results and discussion
Solid phase characterization
Pure SMT and SA, as well as the 1 : 1 co-crystal, each have
only one reported crystalline form. In the present work, the
structures with the CSD refcodes SLFNMD10, SALIAC19 and
GEYSAE have been used. The PXRD pattern obtained for the
1 : 1 co-crystal matches with the simulated pattern obtained
from the structure GEYSAE (Fig. 2a) confirming the purity of
the co-crystal. The co-crystal features strong hydrogen bond-
ing interactions between the hydroxyl and carbonyl function-
alities of SA with the pyrimidine ring nitrogen and the sul-
fonamide N–H group of the SMT, respectively forming a R22(8)
type synthon (Fig. 2b).
Solubility, ternary phase diagram, effect of solvent and
temperature
The solubility of SMT and SA in the three solvents at three
temperatures are given in Table 1, as averages of n = 4 experi-
ments, together with standard deviations. The solubility
values of both coformers in methanol and acetonitrile agree
well with those reported in the literature.57,58 The tempera-
ture dependence of the solubility of pure SMT and SA in 7 : 3
(v/v) DMSO–methanol mixture is shown in Fig. 3 as van't Hoff
plots. In all solvents, the solubility of SA is higher than that
of SMT, by approx. a factor 60 in methanol, 12 in acetonitrile
and 3 in the DMSO–methanol mixture, at 30 °C.
In methanol, the phase diagram (Fig. 4a) is rather asym-
metric as would be expected given the high solubility ratio of
SA to SMT (Table 1), and the co-crystal region is significantly
Fig. 2 Experimental and calculated PXRD patterns for SMT–SA co-crystal (a), main hydrogen-bond motif in the crystal structure of the 1 : 1 SMT–
SA co-crystal (b).51
Table 1 Solubility of SMT and SA in methanol, acetonitrile and 7 : 3 (v/v) DMSO–methanol at three temperatures
Solvent T (°C)
Solubility
(g solute/g solvent) Solubility (mol L−1)
Standard deviation
(mol L−1, n = 4) Solubility ratio
(SA/SMT) (M/M)SMT SA SMT SA SMT SA
Methanol 10 0.0092 0.4788 0.0262 2.7456 0.0010 0.0014 104.7
20 0.0140 0.5688 0.0399 3.2615 0.0011 0.0015 81.7
30 0.0228 0.7007 0.0650 4.0178 0.0013 0.0018 61.8
Acetonitrile 10 0.0102 0.0634 0.0291 0.3742 0.0014 0.0019 12.8
20 0.0151 0.0881 0.0431 0.5051 0.0018 0.0016 11.7
30 0.0209 0.1265 0.0592 0.6827 0.0015 0.0017 11.5
7 : 3 (v/v) DMSO–methanol 20 0.4762 0.7011 1.7237 5.1152 0.0084 0.0079 2.96
30 0.5029 0.7345 1.8202 5.3727 0.0074 0.0081 2.95
























































































CrystEngComm, 2019, 21, 2863–2874 | 2867This journal is © The Royal Society of Chemistry 2019
skewed towards the more soluble component, SA. In addi-
tion, the region where the co-crystal is the stable solid phase
is very narrow. A very narrow co-crystal region makes the
manufacturing process more difficult to design and operate.
The dissolution of the co-crystal is incongruent, i.e. it is not
possible to establish a solid–liquid equilibrium between the
co-crystal solid phase and a stoichiometric solution. For this
reason, the solubility of the co-crystal cannot be determined








(kJ mol−1)xSMT xSA xsolvent HPLC Gravimetry
Methanol 10 SMT + co-crystal 0.0015 0.0056 0.9929 5.8 × 10−3 −6.0
SA + co-crystal 0.0014 0.0066 0.9920 5.4 × 10−3
20 SMT + co-crystal 0.0020 0.0072 0.9908 8.9 × 10−3 −6.5
SA + co-crystal 0.0018 0.0080 0.9902 8.2 × 10−3
30 SMT + co-crystal 0.0030 0.0092 0.9878 1.7 × 10−2 −6.8
SA + co-crystal 0.0027 0.0103 0.9870 1.6 × 10−2
Acetonitrile 10 SMT + co-crystal 0.0022 0.0010 0.9968 7.9 × 10−4 −5.9
SA + co-crystal 0.0004 0.0059 0.9936 1.0 × 10−3
Co-crystal 0.0015 0.0015 0.9969 8.6 × 10−4 0.0293 0.0304
20 SMT + co-crystal 0.0025 0.0012 0.9963 1.1 × 10−3 −6.9
SA + co-crystal 0.0006 0.0064 0.9929 1.7 × 10−3
Co-crystal 0.0017 0.0017 0.9966 1.5 × 10−3 0.0388 0.0404
30 SMT + co-crystal 0.0033 0.0015 0.9952 1.8 × 10−3 −7.2
SA + co-crystal 0.0010 0.0075 0.9914 3.0 × 10−3
Co-crystal 0.0026 0.0026 0.9948 2.7 × 10−3 0.0524 0.0534
DMSO–methanol (7 : 3, v/v) 20 SMT + co-crystal 0.0678 0.0708 0.8613 1.59 −6.8
SA + co-crystal 0.0031 0.1949 0.8019 0.23
30 SMT + co-crystal 0.0696 0.0738 0.8566 1.71 −6.3
SA + co-crystal 0.0042 0.2035 0.7923 0.33
40 SMT + co-crystal 0.0721 0.0758 0.8521 1.84 −6.2
SA + co-crystal 0.0051 0.2143 0.7806 0.44
a Gibbs energy of co-crystal formation.
Table 3 Mass of SMT, SA and solvent input for isothermal slurry conversion, co-crystal mass obtained, and the corresponding co-crystal yield and volu-
metric productivity
Pointa







(g mL−1)SMT SA Solvent
M1 0.0700 0.0600 0.8700 0.1423 0.55 0.06
M2 0.1530 0.0980 0.7490 0.4574 0.91 0.21
A1 0.0620 0.0380 0.9000 0.1460 0.73 0.06
A2 0.1968 0.1032 0.7000 0.5819 0.96 0.26
D1 0.2100 0.2430 0.5470 0.0910 0.10 0.05
D2 0.3540 0.2780 0.3680 0.4857 0.38 0.29
a M (methanol), A (acetonitrile), D (DMSO–methanol).
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by traditional methods. Continued dissolution of this co-
crystal would tend to move the solution composition to the
point where the stable solid phase is a mixture of SMT and
co-crystal, i.e. the invariant point. The phase diagram at three
temperatures as a function of SMT and SA concentrations
has been depicted in Fig. 4b.
In acetonitrile, the solubility of SMT is slightly higher
while that of SA is lower, leading to a reduced solubility ratio
between the two components (Table 1). The phase diagram is
quite symmetric and the co-crystal dissolves congruently.
Since the solubility of SA is still approximately 12 times
higher than that of SMT, the co-crystal region is slightly
skewed towards the SA side of the diagram, i.e. towards the
more soluble component (Fig. 5a). The co-crystal region is
clearly broader than in methanol. Since the co-crystal dis-
solves congruently the solubility of the co-crystal can be gravi-
metrically determined (Table 2). The SMT concentration at
equilibrium with the co-crystal is slightly higher than the
SMT concentration at equilibrium with pure SMT (Fig. 6a),
whereas the SA concentration at equilibrium with the co-
crystal is lower than the SA concentration at equilibrium with
pure SA. The van't Hoff plot of the solubility data for the co-
crystal is shown in Fig. 6b, from the slope (−ΔH/R) of which
the van't Hoff enthalpy of solution is determined to be +22.2
kJ mol−1 (1 : 1 complex). The corresponding values for the
pure components SMT and SA in acetonitrile are +25.4 and
+20.8 kJ mol−1, respectively. The co-crystal value is not too far
from the average of the values of the pure components.
Fig. 4 Zoom-in view of the ternary phase diagram of SMT–SA co-crystal system in methanol at 30 °C. Values are in mass fractions. The blue dot-
ted line is the 1 : 1 stoichiometric line. Regions in the diagram are as follows: (1) solution phase; all other regions consist of a saturated solution in
contact with (2) SMT, (3) SMT + co-crystal (red filled circle), (4) co-crystal (pink filled square), (5) SA, (6) SA + co-crystal (purple inverted triangle).
The circle, square and triangle represent the experimental data. The points M1 and M2 (filled black diamonds) represent starting compositions for
co-crystal yield and volumetric productivity determination (a), phase diagrams at 10 (red), 20 (light blue) and 30 °C (green) in methanol. The
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A 1 : 1 co-crystal ‘AB’ equilibrates with the API ‘A’ and the
coformer ‘B’ in the saturated solution as per eqn (1). The cor-
responding equilibrium constant can be expressed in terms
of thermodynamic activities. In eqn (2), Ksp refers to the solu-
bility product of the co-crystal, when the activity of the solid
co-crystal is taken as unity. Assuming that the contributions
from activity coefficients (γ) can be neglected, Ksp can be ap-
proximated by the product of concentrations of its co-crystal
components, with concentrations in mol L−1. This assump-
tion is valid for ideal solutions, and approximately so for di-
lute solutions where γA and γB are independent of concentra-
tion. The constant Ksp reflects the strength of interactions
between the API and coformer in the co-crystal relative to in-
teractions with the solvent in solution.43 The co-crystal intrin-
sic solubility (SAB) can be estimated from eqn (3) at 10, 20
and 30 °C in acetonitrile (congruent case) using concentra-
tions obtained from HPLC well matching those determined
by the gravimetric method (Table 2).












Ksp = aA,liqaB,liq = γA[A]γB[B] ≈ [A][B] (2)
S KAB sp (3)
A(s) + B(s) → AB(s) (4)
Fig. 5 Zoom-in view of the ternary phase diagram of SMT–SA co-crystal system in acetonitrile at 30 °C. Values are in mass fractions. The blue dot-
ted line is the 1 : 1 stoichiometric line. Regions and various points in the diagram are as same as marked in Fig. 4. The points A1 and A2 (black filled
diamonds) represent starting compositions for co-crystal yield and volumetric productivity determination (a), phase diagrams at 10 (red), 20 (light
blue) and 30 °C (green) in acetonitrile. The horizontal lines are the solubilities of SMT at 10, 20, 30 °C in acetonitrile. The points (filled circles) de-



























































































































Based on the solubility data, the Gibbs energy of forma-
tion of the co-crystal from its pure solid components (eqn
(4)) can be determined by eqn (5), where aliq
A and aliq
B denote
the activities of the solute in a solution in equilibrium with
the pure co-crystal components respectively. aAliq and a
B
liq are
the activities of the co-crystal components in a solution in
equilibrium with pure co-crystal.56 By approximating the activi-
ties with the concentrations in mol L−1, the free energy change
can be estimated. Using the co-crystal solubility data in aceto-
nitrile (a congruent system), the Gibbs energy of co-crystal for-
mation at 10, 20 and 30 °C is estimated to be −5.7, −7.1 and
−7.7 kJ mol−1, respectively. The Gibbs energy of formation has
also been estimated using the average Ksp in the three solvent
systems; the data is reported in Table 2. The values are all
quite close to the values obtained from the co-crystal solubility
data. Altogether, the negative value of the Gibbs energy change
reveals that the formation of the 1 : 1 co-crystal from pure solid
SMT and SA is a spontaneous process, and that the co-crystal
is thermodynamically stable compared to a physical mixture of
pure SMT and SA solid phases. With increasing temperature,
the free energy change becomes more negative, signifying an
increased stability of the co-crystal.
The entropic (eqn (7)) and enthalpic (eqn (8)) components
of the Gibbs energy of formation can be determined:




































The calculated Gibbs energies are plotted in the appropri-
ate coordinates in Fig. 7, from which estimates of the entropy
and the enthalpy of formation are determined from the
slopes. The entropy of co-crystal formation is found to be
0.1015 kJ K−1 mol−1, i.e. the co-crystal formation is associated
with a positive entropy change. The estimated co-crystal en-
thalpy of formation is +23.1 kJ mol−1, which agrees closely
with the average value of +22.8 kJ mol−1 obtained using eqn
(6). Hence, the SMT–SA co-crystal formation from its solid
components is shown to be an endothermic processes, i.e.
energy needs to be provided to synthesize the co-crystal. Ob-
viously, the conclusion is that the formation of the co-crystal
is entirely driven by a favorable entropy increase.
The 7 : 3 (v/v) mixture of DMSO and methanol was chosen
to reach a higher solubility of SMT. The solubility ratio be-
tween the two co-crystal components in this solvent is very
low (∼2.9), and hence this system is expected to be congru-
ent. However, as shown in Fig. 8a, the system is in fact
shown to be incongruent, even though the co-crystal region is
very broad and only slightly skewed away from the 1 : 1 stoi-
chiometric line (Fig. 8a). The effect of temperature on the
phase diagram is shown in Fig. 8b.
In accordance with the SA to SMT solubility ratio, the co-
crystal shows incongruent dissolution in methanol where the
ratio is high and congruent dissolution in acetonitrile where
the ratio is low. However, for an even lower solubility ratio in
7 : 3 (v/v) DMSO–methanol the co-crystal unexpectedly shows
incongruent behaviour. The nature of co-crystal dissolution
was confirmed by separate co-crystal dissolution experiments.
In methanol and DMSO–methanol, the originally pure
cocrystal solid phase transformed into a mixture of solid
SMT and co-crystal, whereas in acetonitrile, a pure co-crystal
solid was maintained. So even if the co-crystal dissolves
nearly congruent in 7 : 3 (v/v) DMSO–methanol it is perfectly
clear that the system is incongruent. In addition, the co-
crystal region for this system does not change systematically
towards the SMT axis compared to the acetonitrile system as
would have been expected from the difference in the solubil-
ity ratio. Accordingly, it can be concluded that the coformer
to API solubility ratio for the SA–SMT system cannot be safely
used as a guide to the nature of the co-crystal dissolution be-
haviour. However, quite clearly the solvent has a major influ-
ence on the nature of co-crystal dissolution and the overall
appearance of the phase diagram.
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Fig. 7 A plot of ΔG vs. T to find the entropy of SMT–SA co-crystal formation (a), Gibbs–Helmholtz plot to determine the enthalpy of SMT–SA
co-crystal formation (b).
Fig. 8 Full-scale ternary phase diagram of the SMT–SA co-crystal system in 7 : 3 (v/v) DMSO–methanol mixture at 30 °C. Values are in mass frac-
tions. The blue dotted line is the 1 : 1 stoichiometric line. Regions and various points in the diagram areas are same as marked in Fig. 4. The points
D1 and D2 (black filled diamonds) represent starting compositions for co-crystal yield and volumetric productivity determination (a), phase dia-
grams at 20 (red), 30 (light blue) and 40 °C (green) in 7 : 3 (v/v) DMSO–methanol. The horizontal lines are the solubilities of SMT at 20, 30, 40 °C in
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With increasing temperature the solubility of all the solid
phases increase, which leads to a shift of the various solid
state regions down towards the solid SMT–SA axis in the ter-
nary phase diagram. This leads to a larger region for the solu-
tion phase region (see Fig. S9–S11 in the ESI†). Temperature
changes did not bring about any remarkable changes on the
overall appearance of the phase diagram.
The experimentally determined invariant points for the
three solvents in terms of mole fractions are given in Table 2,
together with the corresponding Ksp values obtained from
eqn (3). Obviously, the value depends on the solvent. The or-
der in which Ksp varies is DMSO–methanol > methanol >
acetonitrile. In each solvent, the Ksp value and the corre-
sponding co-crystal solubility increase with temperature. In
methanol and acetonitrile, there is just a small difference in
the Ksp values obtained from the two invariant points. How-
ever, in the DMSO–methanol mixture, the Ksp difference is
much higher, most likely because at higher concentrations
the error associated with neglecting the activity coefficients
becomes larger. For the congruent acetonitrile case, the Ksp
for the co-crystal is between the Ksp values obtained from the
two invariant points.
The width of the region where the co-crystal is the most
stable phase can be measured as the linear distance between
the two invariant points as per eqn (9).






Based on this, the width of the co-crystal region decreases
in the order DMSO–methanol > acetonitrile > methanol, and
is inversely proportional to the solubility ratio between the
two co-crystal components (SA/SMT, Table 1) i.e. the smaller
the solubility ratio, the wider the co-crystal region (Fig. 9).
The co-crystal yield and productivity results are given in
Table 3. The starting overall compositions of pure solid
SMT, SA and solvent in the experiments are marked in
Fig. 4, 5 and 8 by (M1, M2), (A1, A2) and (D1, D2), respec-
tively. The farther away from the solid–liquid equilibrium
line this initial overall composition point is placed, the
greater is the surplus of material that can transform into
solid co-crystal, and hence the higher the potential co-
crystal yield and productivity. The difference in yield for the
different solvents primarily depends on the co-crystal solu-
bility. A high solubility leaves a greater amount dissolved in
the solution at the end of the process. The yield can be im-
proved by adding more pure solid components at a stoichio-
metric ratio. The very narrow co-crystal region in methanol
requires a high precision in dosing the components. In
spite of a large co-crystal region in DMSO–methanol, a lim-
iting factor for DMSO–methanol is the high boiling point,
which makes it difficult to completely remove the toxic sol-
vent. Irrespective of the system being congruent or incon-
gruent, the pure co-crystal can be synthesized by slurry co-
crystallization as long as the liquid composition starting
point is along the curve where the co-crystal is in equilib-
rium with the solution. It may be noted that it is favourable
from a yield point of view if the phase diagram is skewed
towards the coformer axis, since this corresponds to a lower
concentration of SMT in the solution.
Conclusions
Ternary phase diagrams have been constructed for
sulfamethazine and salicylic acid in three solvents: methanol,
acetonitrile and a dimethyl sulfoxide–methanol 7 : 3 mixture,
at three temperatures. The shape of the phase diagram de-
pends strongly on the solvent. The choice of solvent can
make the co-crystal system congruent or incongruent, and
can significantly affect the width of the co-crystal region. The
co-crystal dissolves incongruently in methanol and 7 : 3 (v/v)
DMSO–methanol mixture, whereas it shows congruent disso-
lution in acetonitrile. The impact of temperature on the
phase diagram is weak over the 20 °C range investigated. The
solubility ratio of the two co-crystal components does not af-
ford a simple reliable method to predict whether the co-
crystal system becomes congruent or incongruent. The Gibbs
energy of the SMT–SA co-crystal formation from its solid pure
components is estimated to be −5.7, −7.1, and −7.7 kJ mol−1
at 10, 20 and 30 °C, revealing that the co-crystal is thermody-
namically stable in relation to the pure components. In all
three solvents, a slurry conversion process can provide a high
yield and a high volumetric productivity.
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